Compare KODK & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KODK | PAHC |
|---|---|---|
| Founded | 1880 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1994 | 2014 |
| Metric | KODK | PAHC |
|---|---|---|
| Price | $9.64 | $31.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $41.25 |
| AVG Volume (30 Days) | ★ 924.0K | 346.9K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.90 |
| Revenue | ★ $4,114,000,000.00 | $833,350,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ N/A | $16.45 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $4.94 | $23.57 |
| 52 Week High | $14.87 | $60.08 |
| Indicator | KODK | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 38.04 |
| Support Level | $9.13 | $28.25 |
| Resistance Level | $10.18 | $34.49 |
| Average True Range (ATR) | 0.46 | 1.52 |
| MACD | 0.07 | 0.78 |
| Stochastic Oscillator | 55.93 | 57.18 |
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.